Industry is Not the Dark Side, but an Essential Partner to Make Progress in Reproductive Health

被引:2
|
作者
D'Hooghe, Thomas [1 ,2 ,3 ]
机构
[1] Merck, Global Med Affairs Fertil, Darmstadt, Germany
[2] Univ Leuven KU Leuven, Reprod Med, Dept Dev & Regenerat, Leuven, Belgium
[3] Yale Univ, Dept Obstet Gynecol, New Haven, CT 06520 USA
关键词
academia; assisted reproduction; endometriosis; industry; pharma; public health; reproductive medicine; research; university; women's health;
D O I
10.2217/whe.15.106
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
For the last 20 years, Thomas D'Hooghe has been coordinator of the Leuven University Fertility Center at Leuven University Hospitals, Belgium, one of the largest teaching hospitals in Europe. Since 1995, he has also been Professor of Reproductive Medicine and Biology at KU Leuven (University of Leuven) and Adjunct Professor at Yale University, USA. Since 1 October 2015, he has been the Vice President and Head of Global Medical Affairs Fertility at Merck's headquarters in Darmstadt, Germany. He has published nearly 300 papers in internationally peer-reviewed journals and has contributed to reproductive health serving major international organizations such as the WHO, the European Society of Human Reproduction and Embryology, the Society of Reproductive Investigation and the World Endometriosis Research Foundation.
引用
收藏
页码:181 / 184
页数:4
相关论文
共 22 条